Human IL6 kit
No-wash kit to quantify released Human IL6
This HTRF assay is designed to select and characterize compounds that specifically bind human H232 STING protein.
A fast and easy way to identify new binders to human H232 STING.
Stimulator of interferon genes (STING), also known as transmembrane protein 173 (TMEM173), is a protein playing a major role in innate immunity.
The H232 variant is found in 13.7% of the world population. Upon intracellular cytosolic DNA release from pathogens such as viruses and bacteria, 2’-3’cGAMP binds to STING protein and triggers the secretion of type 1 interferon. However, the H232 variant is known to poorly bind 2'-3'cGAMP and other natural dinucleotides. The quest for molecules that are effective against all genetic variants has become crucial to modulate immunity in autoinflammatory diseases.
The HTRF H232 STING binding assay is a competitive assay format which uses d2-labeled H232 STING ligand, a 6His tagged human H232 STING protein, and an anti 6His Cryptate-labeled antibody. Your compound competes with the H232 STING ligand-d2 and thereby prevents FRET from occurring.
The Human H232 STING binding assay can be run in a 96- or 384-well low volume white plate (20 µL final). As described here, samples or standards are dispensed directly into the assay plate. The human His-tagged H232 STING protein is then added, followed by the dispensing of the HTRF reagents: the anti 6His antibody labeled with Terbium cryptate and the H232 STING ligand labeled with d2. The reagents labeled with HTRF fluorophores may be pre-mixed and added in a single dispensing step. No washing steps are needed. The protocol can be further miniaturized or upscaled by simply resizing each addition volume proportionally.
Various compounds known to be STING ligands were added to the assay.
2'3'cGAMP displays a low affinity for the H232 variant in the µM range, compared its high affinity against WT Sting (Ki=2.5nM). Similarly, the other bacterial compounds such as 3'3' cGAMP, cyclic di-AMP, and cyclic d-GMP, or the reference compound ADU-S100, show Ki constants in the µM.
The assay standard corresponding to a derivative of the labeled ligand is more potent, with a Ki at 13.4nM.
DMXAA, a non-specific compound and also a well-known mouse STING binder, has no effect on the assay, confirming the human specificity of the kit.
STING, for STimulator of INterferon Genes, is a cytoplasmic homodimeric protein localized in the endoplasmic reticulum and which plays an essential role in innate immunity. Upon pathogen infection or mitochrondrial shrinking during apoptosis, floating dsDNAs bind and activate a DNA sensor, cyclic GMP-AMP synthase (cGAS). Activated cGAS leads to the production of 2’-3’cGAMP, a cyclic dinucleotide, which then binds to STING proteins. In turn, phosphorylated STING interacts with TANK-binding-kinase-I (TBK1), leading to the recruitment and activation of the active interferon regulatory factor (IRF3) dimer. Nuclear translocation of the IRF3 dimer leads to the transcription of genes encoding IFN-α/β. In addition, the STING pathway controls NF-κB dependent inflammatory cytokine expression. As a negative feedback loop, the DNA-stimulated cGAS-STING-TBK1 pathway also triggers STING protein degradation through p62 SQSTM1 associated autophagy, to switch off IFNb production.
Easy pharmacological characterization of PPI modulators. - Technical Notes
Deciphering low- and high affinity interactions - Application Notes
Monitoring nuclear receptor binding with HTRF assays - Application Notes
Challenge large complexes with HTRF assays - Application Notes
Get the brochure about technology comparison. - Brochures
cGAS-STING signaling pathway from A to Z - Brochures
Featuring a panel of experts - Videos
Explore the whole STING pathway with a single technology - Posters
See how peer researchers challenge the viral life cycle with PPI assays - Application Notes